mRNA |
erlotinib:PLX-4032 (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.034 |
0.4 |
mRNA |
lovastatin |
CTRPv2 |
pan-cancer |
AAC |
0.033 |
0.4 |
mRNA |
ML312 |
CTRPv2 |
pan-cancer |
AAC |
0.069 |
0.4 |
mRNA |
MK-2206 |
CTRPv2 |
pan-cancer |
AAC |
0.032 |
0.4 |
mRNA |
PI-103 |
CTRPv2 |
pan-cancer |
AAC |
0.031 |
0.4 |
mRNA |
SNX-2112:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.029 |
0.4 |
mRNA |
selumetinib:vorinostat (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.032 |
0.4 |
mRNA |
UNC0638:navitoclax (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.032 |
0.4 |
mRNA |
BMS-536924 |
CTRPv2 |
pan-cancer |
AAC |
0.031 |
0.4 |
mRNA |
Cerulenin |
CTRPv2 |
pan-cancer |
AAC |
0.028 |
0.4 |